BioWorld

Oct. 17, 2016

View Archived Issues

BioWorld stock report for public biotechnology companies

The week's biggest gainers and losers

Money raised by biotech: Jan. 1 - Oct. 14, 2016

Money raised by biotech in 2016 vs. 2015

Regulatory submissions, approvals & other actions: September 2016

Phase III clinical trials update: September 2016

Phase II clinical trials update: September 2016

Phase I clinical trials update: September 2016

Cannabinoids medicalized for multiple indications

Marijuana has been used as a medical treatment for centuries. But there’s only one cannabinoid-based drug on the market, Marinol (dronabinol, Abbvie Inc.), which was approved back in 1985. Read More

Week in review

Week in Washington

Word on the street

FDA approvals in September

Today's news in brief

BioWorld

BioWorld briefs for Jan 12, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for Jan. 12, 2026.

3D rendering of antibody drug conjugated with cytotoxic payload

ADCs’ breakout 2025 and their still-unfinished potential

BioWorld Science

Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...

LINC01116 has prognostic value in lung cancer, study shows

BioWorld Science

Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...

ADCs’ breakout 2025 and their still-unfinished potential

BioWorld

Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...